Patents by Inventor Lawrence Perez

Lawrence Perez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
    Publication number: 20080114167
    Abstract: The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Application
    Filed: August 21, 2007
    Publication date: May 15, 2008
    Applicant: Infinity Discovery, Inc.
    Inventors: Alfredo CASTRO, Kristopher DEPEW, Michael GROGAN, Charles JOHANNES, Edward HOLSON, Brian HOPKINS, Gregg KEANEY, Nii KONEY, Tao LIU, David MANN, Marta NEVALAINEN, Stephane PELUSO, Lawrence PEREZ, Daniel SNYDER, Thomas TIBBITTS
  • 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
    Publication number: 20070060582
    Abstract: This invention relates to compounds of the formula (I) wherein the variable substituents are described herein. The compounds are useful for the treatment of conditions and diseases characterized by an aberrant MAP kinase signaling pathway, such as cancer.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 15, 2007
    Inventors: Cynthia Fink, Lawrence Perez, Timothy Ramsey, Naeem Yusuff, Richard Versace, David Batt, Michael Sabio, Sunkyu Kim
  • Deacetylase inhibitors
    Publication number: 20060189674
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Application
    Filed: April 20, 2006
    Publication date: August 24, 2006
    Inventors: Stacy Remiszewski, Kenneth Bair, Richard Versace, Lawrence Perez, Michael Green, Lidia Sambucetti, Sushil Sharma
  • Trifluoromethyl substituted benzamides as kinase inhibitors
    Publication number: 20060035897
    Abstract: The invention relates to trifluoromethyl substituted benzamide compounds of the formula I, pharmaceuticals comprising these compounds, their use as or for the manufacture of pharmaceuticals, particularly as inhibitors of protein kinases, especially of ephrin receptor kinases, and/or the treatment of a condition, disorder or disease state mediated by a protein kinase activity and/or a proliferative disease, methods of treatment comprising administering the compounds, especially of therapeutic and prophylactic treatment, methods for the manufacture of the compounds and novel intermediates and partial steps for their synthesis.
    Type: Application
    Filed: August 10, 2005
    Publication date: February 16, 2006
    Inventors: Giorgio Caravatti, Pascal Furet, Patricia Imbach, Georg Martiny-Baron, Lawrence Perez, Tao Sheng
  • Deacetylase inhibitors
    Publication number: 20050085507
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Application
    Filed: November 9, 2004
    Publication date: April 21, 2005
    Inventors: Stacy Remiszewski, Kenneth Bair, Richard Versace, Lawrence Perez, Michael Green, Lidia Sambucetti, Sushil Sharma